Money Concepts Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Buy
+3,497
New +$201K 0.01% 614
2023
Q1
– Sell
-25,735
Closed -$1.85M – 757
2022
Q4
$1.85M Buy
25,735
+8,227
+47% +$620K 0.08% 196
2022
Q3
$1.25M Sell
17,508
-73
-0.4% -$5.29K 0.07% 208
2022
Q2
$1.35M Sell
17,581
-21,896
-55% -$1.67M 0.12% 174
2022
Q1
$2.88M Buy
39,477
+31,095
+371% +$2.09M 0.16% 143
2021
Q4
$523K Buy
+8,382
New +$492K 0.04% 306
2021
Q1
$468K Sell
7,409
-3,134
-30% -$195K 0.04% 325
2020
Q4
$654K Buy
+10,543
New +$648K 0.06% 249

Other funds holding BMY

Money Concepts Capital's BMY Position: Q2 2026 in Review

Money Concepts Capital opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 3,497 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #614 among its holdings. This is a return to the name: Money Concepts Capital previously reported a position in BMY as recently as Q4 2022.

Money Concepts Capital first reported a position in BMY in Q4 2020 and has held it in 8 quarters since. The position peaked at $2.88M in Q1 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Money Concepts Capital held 3,497 shares of Bristol-Myers Squibb worth $202K as of Q2 2026.
  • Bristol-Myers Squibb was a new Money Concepts Capital position in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Money Concepts Capital's portfolio in Q2 2026, its #614 holding.
  • Money Concepts Capital first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 8 quarters since.
  • Money Concepts Capital's Bristol-Myers Squibb position peaked at $2.88M in Q1 2022.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.